Correction: Cytokine Receptor-Like Factor 1 () Protects against 6-Hydroxydopamine Toxicity Independent of the gp130/JAK Signaling Pathway.

Correction: Cytokine Receptor-Like Factor 1 () Protects against 6-Hydroxydopamine Toxicity Independent of the gp130/JAK Signaling Pathway.

Bibliographic Details
Main Authors:	Brendan D. Looyenga, James Resau, Jeffrey P. MacKeigan
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3882296

Similar Items

Cytokine receptor-like factor 1 (CRLF1) protects against 6-hydroxydopamine toxicity independent of the gp130/JAK signaling pathway.
by: Brendan D Looyenga, et al.
Published: (2013-01-01)

Correction: Cytokine Receptor-Like Factor 1 (CRLF1) Protects against 6-Hydroxydopamine Toxicity Independent of the gp130/JAK Signaling Pathway
Published: (2014-01-01)

The Role of gp130 Cytokines in Tuberculosis
by: Kristina Ritter, et al.
Published: (2020-12-01)

GP130 Cytokines in Breast Cancer and Bone
by: Tolu Omokehinde, et al.
Published: (2020-01-01)

Absence of GP130 cytokine receptor signaling causes extended Stüve-Wiedemann syndrome
by: Chen, Y, et al.
Published: (2020)

Crystal structure of a cytokine-binding region of gp130.
by: Bravo, J, et al.
Published: (1998)

Sepsis induces interleukin 6, gp130/JAK2/STAT3, and muscle wasting
by: Lukas Zanders, et al.
Published: (2022-02-01)

Nonspecific Inhibition of IL6 Family Cytokine Signalling by Soluble gp130
by: Anissa A. Widjaja, et al.
Published: (2024-01-01)

The dynamics of signal triggering in a gp130-receptor complex.
by: Matadeen, R, et al.
Published: (2007)

A GP130-Targeting Small Molecule, LMT-28, Reduces LPS-Induced Bone Resorption around Implants in Diabetic Models by Inhibiting IL-6/GP130/JAK2/STAT3 Signaling
by: Qi-qi Liu, et al.
Published: (2023-01-01)

A Mitochondrial RNAi Screen Defines Cellular Bioenergetic Determinants and Identifies an Adenylate Kinase as a Key Regulator of ATP Levels
by: Nathan J. Lanning, et al.
Published: (2014-05-01)

p42/p44-MAPK and PI3K are sufficient for IL-6 family cytokines/gp130 to signal to hypertrophy and survival in cardiomyocytes in the absence of JAK/STAT activation.
by: Fahmi, A, et al.
Published: (2013)

P42/p44-MAPK and PI3K are sufficient for IL-6 family cytokines/gp130 to signal to hypertrophy and survival in cardiomyocytes in the absence of JAK/STAT activation
by: Fahmi, A, et al.
Published: (2013)

Modulation of the IL-6-Signaling Pathway in Liver Cells by miRNAs Targeting gp130, JAK1, and/or STAT3
by: Florence A. Servais, et al.
Published: (2019-06-01)

Structures of the interleukin 11 signalling complex reveal gp130 dynamics and the inhibitory mechanism of a cytokine variant
by: Riley D. Metcalfe, et al.
Published: (2023-11-01)

Rol' retseptora tsitokinov gp130 v gemopoeze
by: N N Tupitsyn
Published: (2001-03-01)

Point mutation of tyrosine 759 of the IL-6 family cytokine receptor, gp130, augments collagen-induced arthritis in DBA/1J mice
by: Ishihara Katsuhiko, et al.
Published: (2009-02-01)

Transcytosis of IL-11 and Apical Redirection of gp130 Is Mediated by IL-11α Receptor
by: Niloufar Monhasery, et al.
Published: (2016-07-01)

Cytoplasmic LMO2-LDB1 Complex Activates STAT3 Signaling through Interaction with gp130-JAK in Glioma Stem Cells
by: Cheol Gyu Park, et al.
Published: (2022-06-01)

gp130 cytokines are positive signals triggering changes in gene expression and axon outgrowth in peripheral neurons following injury
by: Richard eZigmond
Published: (2012-01-01)

STAT3 Signalling via the IL-6ST/gp130 Cytokine Receptor Promotes Epithelial Integrity and Intestinal Barrier Function during DSS-Induced Colitis
by: Lokman Pang, et al.
Published: (2021-02-01)

IL-6/gp130 signaling: a key unlocking regeneration
by: Ruopu Li, et al.
Published: (2023-03-01)

Bazedoxifene as a novel GP130 inhibitor for Colon Cancer therapy
by: Jia Wei, et al.
Published: (2019-02-01)

A biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosis
by: Schwerd, T, et al.
Published: (2017)

Unique Metabolic Contexts Sensitize Cancer Cells and Discriminate between Glycolytic Tumor Types
by: Jonathan A. Chacon-Barahona, et al.
Published: (2023-02-01)

Expression of Carboxypeptidase X M14 Family Member 2 Accelerates the Progression of Hepatocellular Carcinoma via Regulation of the gp130/JAK2/Stat1 Pathway
by: Ye Y, et al.
Published: (2020-03-01)

Circulating Levels of IL‐6 Receptor and gp130 and Long‐Term Clinical Outcomes in ST‐Elevation Myocardial Infarction
by: Vibeke N. Ritschel, et al.
Published: (2016-06-01)

Hepatocyte Specific gp130 Signalling Underlies APAP Induced Liver Injury
by: Jinrui Dong, et al.
Published: (2022-06-01)

gp130 Activates Mitochondrial Dynamics for Hepatocyte Survival in a Model of Steatohepatitis
by: Daria Shunkina, et al.
Published: (2023-01-01)

Interleukin 6/gp130 axis promotes neural invasion in pancreatic cancer
by: Hidetaka Suzuki, et al.
Published: (2022-12-01)

The Alzheimer’s disease-linked protease BACE1 modulates neuronal IL-6 signaling through shedding of the receptor gp130
by: Stephan A. Müller, et al.
Published: (2023-02-01)

NOTCH Activation via gp130/STAT3 Signaling Confers Resistance to Chemoradiotherapy
by: Kristin Koerdel, et al.
Published: (2021-01-01)

Cannabis Use Is Associated With Increased Levels of Soluble gp130 in Schizophrenia but Not in Bipolar Disorder
by: Attila Szabo, et al.
Published: (2020-07-01)

Quantitation of Tissue Amyloid via Fluorescence Spectroscopy Using Controlled Concentrations of Thioflavin-S
by: Tatiana P. MacKeigan, et al.
Published: (2023-06-01)

Downregulation of the mitochondrial phosphatase PTPMT1 is sufficient to promote cancer cell death.
by: Natalie M Niemi, et al.
Published: (2013-01-01)

Computational analysis of an autophagy/translation switch based on mutual inhibition of MTORC1 and ULK1.
by: Paulina Szymańska, et al.
Published: (2015-01-01)

Chemical Biology Screening Identifies a Vulnerability to Checkpoint Kinase Inhibitors in TSC2-Deficient Renal Angiomyolipomas
by: Robert M. Vaughan, et al.
Published: (2022-03-01)

The fiber metabolite butyrate reduces gp130 by targeting TRAF5 in colorectal cancer cells
by: Yin Yuan, et al.
Published: (2020-06-01)

Signaling Through gp130 Compromises Suppressive Function in Human FOXP3+ Regulatory T Cells
by: Khalid Bin Dhuban, et al.
Published: (2019-07-01)

Mitochondrial morphological features are associated with fission and fusion events.
by: Laura M Westrate, et al.
Published: (2014-01-01)